Investigating the link between HPV genotypes and cervical abnormality incidence in women with HPV infections: insights from a leading referral centre
Open Access
- 31 July 2025
- journal article
- research article
- Published by Springer Nature in Virology Journal
- Vol. 22 (1) , 1-8
Abstract
Cervical cancer (CC) is a serious health issue, especially in low- and middle-income countries, primarily caused by human papillomavirus (HPV) infection, particularly genotypes 16 and 18. Other risk factors include smoking, early sexual activity, and long-term oral contraceptive use. Early detection through cervical cytology and HPV testing is vital for effective prevention. This study aimed to analyze the clinical and epidemiological characteristics of cervical intraepithelial neoplasia (CIN) in HPV-positive women at a Tehran teaching hospital, focusing on HPV genotypes and their association with CIN. We conducted a cross-sectional study of HPV-positive women who underwent Pap smear testing, HPV genotyping via real-time PCR, and colposcopy with biopsies of suspected lesions. Risk factors like smoking and alcohol consumption were evaluated, and statistical analyses were performed, including ordinal logistic regression. Among participants, 52.4% had abnormal CIN: CIN I (31.1%), CIN II (11.4%), and CIN III (10.0%). HPV-16 was the most prevalent genotype (43.7%), significantly associated with severe CIN outcomes (odds ratio [OR] = 2.88, 95% CI), followed by HPV-18 (OR = 1.87, 95% CI). Smoking increased the risk of severe CIN (OR = 1.53, 95% CI), while older age and later age at sexual debut correlated with better CIN outcomes. HPV-16 and smoking are major predictors of severe CIN, highlighting the need for targeted interventions such as HPV vaccination and smoking cessation, along with regular screenings to lower cervical cancer risks. Additional research is required to evaluate the persistence of different HPV genotypes and their progression to CIN and cervical cancer.”Keywords
This publication has 21 references indexed in Scilit:
- Toward a Framework to Assess the Financial and Economic Burden of Cervical Cancer in Low- and Middle-Income Countries: A Systematic ReviewJCO Global Oncology, 2024
- Prevalence of human papillomavirus infection and associated factors among women attending cervical cancer screening in setting of Addis Ababa, EthiopiaScientific Reports, 2024
- Is smoking an independent risk factor for developing cervical intra-epithelial neoplasia and cervical cancer? A systematic review and meta-analysisExpert Review of Anticancer Therapy, 2021
- Cervical Cancer Screening: Past, Present, and FutureSexual Medicine Reviews, 2019
- Human Papillomavirus Infection and Cervical Cancer: Epidemiology, Screening, and Vaccination—Review of Current PerspectivesJournal of Oncology, 2019
- Human papillomavirus and cervical cancerJournal of Obstetrics and Gynaecology, 2019
- Clearance of Type-Specific, Low-Risk, and High-Risk Cervical Human Papillomavirus Infections in HIV-Negative and HIV-Positive WomenJournal of Global Oncology, 2018
- Prevalence and risk factors for cervical cancer and pre-cancerous lesions in RwandaPan African Medical Journal, 2015
- Smoking as a major risk factor for cervical cancer and pre-cancer: Results from the EPIC cohortInternational Journal of Cancer, 2013
- The role of co-factors in the progression from human papillomavirus infection to cervical cancerGynecologic Oncology, 2013